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ABSTRACT 17 
In a previous microarray study we identified a subset of miRNAs which expression was 18 
distinctly higher in atretic than healthy follicles of cattle. In the present study we investigated 19 
the involvement of those miRNAs in granulosa and theca cells during atresia. RT-qPCR 20 
confirmed that miR-21-5p/-3p, miR-150, miR-409a, miR-142-5p, miR-378, miR-222, miR-21 
155 and miR-199a-5p were expressed at higher levels in atretic than healthy follicles (9-17 22 
mm, classified based on steroidogenic capacity). All miRNAs except miR-21-3p and miR-23 
378 were expressed at higher levels in theca than granulosa cells. The expression of 13 24 
predicted miRNA targets was determined in follicular cells by RT-qPCR, revealing 25 
downregulation of HIF1A, ETS1, JAG1, VEGFA and MSH2 in either or both cell types during 26 
atresia.  Based on increases in miRNA levels simultaneous with decreases in target levels in 27 
follicular cells, several predicted miRNA-target interactions were confirmed that are 28 
putatively involved in follicular atresia, namely miR-199a-5p/miR-155-HIF1A in granulosa 29 
cells, miR-155/miR-222-ETS1 in theca cells, miR-199a-5p-JAG1 in theca cells, miR-199a-30 
5p/miR-150/miR-378-VEGFA in granulosa and theca cells, and miR-155-MSH2 in theca 31 
cells. These results offer novel insight on the involvement of miRNAs in follicle development 32 
by identifying a miRNA-target network that is putatively involved in follicle atresia. 33 
Keywords: miRNAs, follicle, follicle atresia, bovine, granulosa, theca 34 
 35 
1. Introduction 36 
The overwhelming majority of follicles recruited from the primordial pool during a 37 
female’s reproductive life will undergo atresia before they can reach the ovulatory stage. 38 
Atresia is an active process involving not only cell death but also resorption of follicular 39 
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tissue and its replacement by stromal and new follicular tissue; these processes involve 40 
infiltration by immune and other cells, very much resembling wound healing [1].  Among 41 
several key regulators of wound healing and tissue remodeling processes across body tissues 42 
are microRNAs (miRNAs) [2].  43 
The involvement of miRNAs in different aspects of follicle development has been 44 
demonstrated in numerous studies [3,4]. Much of the existing evidence has been obtained 45 
using follicular cell cultures, mostly granulosa cells. Often reported effects of miRNAs 46 
include either the promotion or suppression of granulosa cell apoptosis [5-10]. Yet, in many 47 
cases, the site of expression, if any, of these miRNAs within follicles (i.e., granulosa and 48 
theca compartments) or whether their expression actually changes during follicle atresia, 49 
supporting their physiological role, has not been clarified.  Moreover, although the 50 
posttranscriptional effects of miRNAs in tissues often involve targeting of a common gene 51 
simultaneously by several miRNAs and, at the same time, a single miRNA can 52 
simultaneously target multiple genes, previous functional studies in follicles have often used 53 
a one miRNA – one target approach thus providing limited information on the wider 54 
biological effects of miRNAs expressed simultaneously acting in co-ordination.   55 
In a previous study we used microarray to profile miRNA expression across a wide range 56 
of antral follicle development stages in cattle [11], a species which follicular physiology 57 
closely resembles the human, particularly when compared to rodents; by comparing miRNA 58 
profiles between steroidogenic-active and steroidogenic-inactive follicles, we identified a 59 
subset of miRNAs that are putatively involved in the growth of healthy dominant follicles. In 60 
the present study we focused our attention on those miRNAs identified as upregulated during 61 
follicle atresia in our previous study. Specifically, we established and compared the 62 
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expression of miRNAs and their putative targets within the follicular granulosa and theca 63 
compartments to gain insight into their involvement in follicle atresia. 64 
 65 
2. Materials & methods 66 
2.1 Collection and processing of bovine tissues 67 
Follicles from ovaries of cycling beef cattle obtained at an abattoir were collected as part 68 
of a separate study [11]. Individual follicles 9-17 mm in diameter were dissected out and the 69 
follicular fluid aspirated and centrifuged at 800 g for 10 min. The resulting supernatant was 70 
stored at –80 °C until further analyses and the cell pellet was combined with the follicular 71 
wall free of surrounding stroma and snap-frozen in liquid nitrogen until RNA extraction. 72 
Alternatively, after hemi-dissection, follicles were gently scraped with blunt-ended forceps to 73 
collect granulosa and theca wall compartments. Theca walls were washed repeatedly to 74 
remove any residual granulosa cells. Theca and granulosa cells from each individual follicle 75 
were then separately snapped frozen in liquid nitrogen.  76 
Intra-follicular concentrations of estradiol and progesterone were measured using 77 
competitive double antibody radioimmunoassay kits (Siemens Healthcare Diagnostics Inc., 78 
USA) following the manufacturer’s instructions. All assays were validated in our laboratory 79 
by showing parallelism between serial sample dilutions and the provided assay standard 80 
curve. Sensitivity of the assays was 0.56 ng / mL and 0.01 ng / mL, and the intra-assay CVs 81 
were 6 % and 4.3 % for estradiol and progesterone, respectively.  82 
2.2  RT-qPCR 83 
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Total RNA was extracted using the miRNeasy Mini kit (Qiagen, UK) and reverse-84 
transcribed using the miScript II RT kit (Qiagen), as described [11]. Messenger RNA levels 85 
were quantified using the SensiFASTTM SYBR Lo-ROX Kit (Bioline Reagents Ltd, UK) and 86 
bovine-specific primers (Table 1). For miRNA quantification the miScript SYBR Green PCR 87 
kit and miScript Primer Assays (Qiagen) were used. All PCRs were run on a MX3005P 88 
QPCR system (Stratagene, CA, USA) using a standard curve to calculate copy numbers from 89 
Cq values [11]. Messenger RNA data were normalized using 18S values within each sample 90 
and miRNA data were normalized using endogenous RnU6-2.  Mean intra-assay CVs for 91 
miRNA and mRNA qPCRs were 9.5% and 11.3%, respectively.  92 
2.3  miRNA target identification 93 
Identification of putative miRNA targets was done using miRTarBase release 6.0 and 94 
TargetScan release 7.0 to select targets experimentally validated in human and/or rodents (by 95 
reporter assay, western blot and/or RT-qPCR, as detailed in 96 
http://mirtarbase.mbc.nctu.edu.tw/) and computationally predicted targets within the bovine 97 
genome (http://www.targetscan.org), respectively.  For convenience, each identified miRNA-98 
target interaction was classified as high-, medium- or low-confidence based on whether it was 99 
present in both miRTarBase and TargetScan, miRTarBase only or TargetScan only.  100 
2.4  Statistical analyses 101 
ROUT outlier test was applied to data sets, and outlier values (P < 0.01) were excluded 102 
from subsequent analyses. Gene expression data were assessed for normality using the 103 
D'Agostino & Pearson normality test and were log-transformed prior to statistical analysis 104 
where necessary. Two-way ANOVA followed by unpaired t-tests to identify differences in 105 
gene expression between healthy and atretic follicles within each cell type were used. 106 
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Significance was considered at P < 0.05 whereas differences with P values < 0.1 were 107 
considered to approach significance. Nomenclature according to miRBase release 21 is used 108 
throughout the manuscript. All miRNAs referred to are bovine (bta-) except otherwise 109 
specified. 110 
 111 
3. Results 112 
3.1  miRNA expression analyses in follicular tissues 113 
In a previous study in cattle [11], microarray analyses yielded a total of 11 unique bovine 114 
sequences which were expressed in greater abundance (> 1.5 fold) in atretic than in healthy 115 
pre-ovulatory-size follicles (Table 2). The status of the follicles analyzed in that study had 116 
been pre-determined on the basis of steroidogenic capacity and LHGCR expression in 117 
granulosa cells (Figure 1). Microarray results were validated by RT-qPCR in the present 118 
study, confirming the up-regulation of 9 miRNAs in atretic follicles (Table 2).  119 
To gain insight on the involvement of these miRNAs in follicle development we 120 
quantified their relative expression in granulosa and theca cell compartments. This showed 121 
that all miRNAs except for miR-21-3p and miR-378 were expressed in greater abundance 122 
(between 2-fold and 25-fold) in theca than in granulosa cells (Cell type, P < 0.05; Figure 2). 123 
Moreover, an effect of Follicle Status (P < 0.05), owing to overall higher expression levels in 124 
atretic follicles, was detected for all miRNAs except miR-21-5p and miR-378; for miR-378, 125 
an interaction approached significance (P = 0.07), reflecting higher expression levels in 126 
granulosa but not theca cells from atretic follicles. 127 
3.2  Identification and expression analyses of miRNA targets  128 
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To identify putative targets of the 9 miRNAs in cattle we used miRTarBase, a database 129 
containing experimentally validated targets of human, mouse and rat miRNAs, and we 130 
selected 36 genes that were simultaneous targets of ≥ 2 of those miRNAs (Table S1). To 131 
increase confidence in our target selection, we then searched all 36 genes in TargetScan and 132 
selected those, 16 in total, which bovine homologues were computationally predicted targets 133 
of one or more of the corresponding bovine miRNA sequences (Table S1).  Finally, we 134 
assessed the validity of these predictions by analyzing by qPCR the expression in follicular 135 
cells of 8 of the 16 genes identified (Table 3 and Figure 3; an additional two targets, E2F2 136 
and SIRT1, were also selected but could not be detected in follicular cells by RT-qPCR). For 137 
completeness, our qPCR analyses also included one gene (MYD88) which interactions with 138 
two miRNAs were experimentally validated but not computationally predicted in bovine 139 
(Table 3 and Figure 3), and 2 genes, IGF1 and PAPPA, which were computationally 140 
predicted bovine targets of 2 miRNAs (miR-222 and miR-378) and 3 miRNAs (miR-142-5p, 141 
miR-150 and miR-378), respectively, but none of which were experimentally validated in any 142 
species, i.e., they were present in TargetScan but not in miRTarBase (Table 3 and Figure 3).  143 
As shown in Figure 3, out of the remaining miRNA targets, 8 were enriched (Cell type, P 144 
< 0.05) in either granulosa cells (HIF1A, IGF1R and PAPPA) or theca cells (ETS1, JAG1, 145 
MSH2, IGF1 and TIMP3A), and 5 targets were differentially expressed according to follicle 146 
status, in all cases involving a reduction in atretic follicle cells, as indicated by a significant 147 
effect of Follicle Status or a Follicle Status x Cell Type interaction (HIF1A, ETS1, JAG1, 148 
VEGFA and MSH2).   149 
3.3  Validation of miRNA-target interactions  150 
Comparing miRNA and mRNA expression profiles (Figures 2 and 3) allowed for the 151 
testing, based on a negative association between the expression of a miRNA and that of its 152 
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predicted target(s) within a follicular cell type, of a total of 12 high-confidence miRNA-target 153 
interactions (i.e., obtained from both miRTarBase and TargetScan; indicated by dark grey in 154 
Table 3), 8 medium-confidence interactions (obtained from miRTarBase but not present in 155 
TargetScan; indicated by light grey in Table 3) and 5 low-confidence interactions (identified 156 
in TargetScan but not present in miRTarBase; indicated by an “X” in Table 3).  157 
Out of the 12 predicted high–confidence interactions analyzed, 5 were confirmed by RT-158 
qPCR, specifically involving miR-199a-5p and HIF1A in granulosa cells, miR-155/miR-222 159 
and ETS1 in theca cells, miR-199a-5p and JAG1 in theca cells, and miR-199a-5p and VEGFA 160 
in both granulosa and theca cells (miRNAs indicated in bold in Figure 3A).  For another 3 161 
predicted high-confidence interactions, differences in mean miRNA and target levels did not 162 
reached significance (P < 0.1). These involved JAG1 and miR-21-5p in theca cells, MSH2 163 
and miR-21-5p in theca cells and IGF1R and miR-378 in granulosa cells (Figure 3A,B). Four 164 
predicted high-confidence interactions involving TIMP3 and RECK1 were not confirmed as 165 
the levels of these transcripts did not change significantly according to Follicle status (Figure 166 
3B).  167 
Out of 8 predicted medium-confidence interactions analyzed (Table 3), 4 were confirmed 168 
involving miR-155 and HIF1A in granulosa cells, miR-150 and VEGFA in both granulosa 169 
and theca cells, miR-378 and VEGFA in granulosa cells, and miR-155 and MSH2 in theca 170 
cells (Figure 3A). For another 2 medium-confidence interactions, involving miR-21-5p and 171 
VEGFA in both granulosa and theca cells, and IGF1R and miR-21-5p in granulosa cells 172 
(Figure 3A,B), differences in mean miRNA and target levels did not reached significance (P 173 
< 0.1), while the remaining 2 medium-confidence interactions were not confirmed as the 174 
levels of MYD88 did not change with follicle status (Figure 3B).   175 
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Finally, none of the 5 low-confidence interactions (Table 3) tested were confirmed as 176 
transcript abundance of IGF1 and PAPPA did not change according to Follicle status (Figure 177 
3B). 178 
 179 
4. Discussion 180 
A limited number of studies in cattle [11,12] and pigs [8] have reported genome-wide 181 
miRNA expression profiles associated with follicle atresia. Five of the 9 miRNAs confirmed 182 
to be upregulated in atretic follicles in the present study (miR-21-5p, miR-21-3p, miR-222, 183 
miR-155, miR-199a-5p) were also found to be increased in subordinate relative to dominant 184 
follicles on Day 3 of the bovine estrous cycle using deep-sequencing rather than microarray 185 
[12]. Another miRNA, miR-378, was previously shown, together with miR-21-5p, to increase 186 
in expression in subordinate and anovulatory follicles in horses [13,14]. Taken together, these 187 
results are consistent with an involvement of these miRNAs in follicular atresia in the 188 
monovular ovary. Indeed, all 9 miRNAs identified in atretic follicles in this study can 189 
reportedly regulate cell survival and/or tissue turnover [15-21]. Specifically in the ovary, 190 
miR-21 promotes cell survival during luteinization [10] while at the same time is expressed at 191 
very high abundance in the regressing corpus luteum [22], suggesting a multifaceted, 192 
developmental stage-dependent involvement in follicle and corpus luteum function. A 193 
putative involvement of miR-378 in regulating luteal cell survival in bovine has been 194 
suggested but not proven [23]. However, in the pig, miR-378 targets aromatase and 195 
progesterone receptor in granulosa cells and regulates both ovarian estradiol production and 196 
oocyte maturation [24-26] Finally, another of the miRNAs investigated in our study, mir-222, 197 
may reportedly regulate steriodogenesis of granulosa cells [27]. 198 
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Our miRNA-target pair analyses provides novel insight on the molecular regulation of 199 
follicular atresia by identifying specific miRNA networks putatively involved within different 200 
follicular compartments (summarized in Figure 4). To identify high-confidence bovine 201 
miRNA targets we selected genes that both 1) had already been experimentally validated for 202 
2 or more miRNAs in different cellular contexts in humans and/or rodents (as bovine-specific 203 
information is not available) and 2) contained predicted miRNA target sites in the bovine 204 
homolog 3’UTR. In choosing this approach we took into consideration that 1) effective target 205 
downregulation often involves multiple miRNAs simultaneously binding the 3’UTR of a 206 
gene and 2) computational prediction of miRNA targets is relatively inaccurate in terms of 207 
both false targets being identified and true targets being missed. A similar proportion of 208 
predicted miRNA-target interactions classified as high-confidence (identified from both 209 
miRTarBase and TargetScan) and medium-confidence (identified from miRTarBase only) 210 
were confirmed by qPCR (5 out of 12 and 4 out 8, respectively), with another 3 and 2 211 
interactions failing to be validated because miRNA and/or mRNA expression differences 212 
only approached significance (P < 0.1). These results highlight the notion that a significant 213 
number of true miRNA targets are normally missed using computational prediction 214 
approaches, and that the fact that a target has been experimentally validated in other species 215 
may provide the strongest rationale for target selection, particularly considering that many 216 
miRNAs are functionally conserved. It needs to be pointed out that failure to detect 217 
differences in predicted target levels by RT-qPCR (e.g., MYD88 in this study) does never by 218 
itself provide conclusive evidence that the gene in question is not an actual target, as miRNAs 219 
may in general have greater effects on protein than transcript levels. Unfortunately, 220 
quantification of protein levels is not always possible in bovine due to the limited availability 221 
of species-specific antibodies.  222 
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Among the genes confirmed as miRNA targets in atretic follicles was VEGFA, which 223 
expression was significantly downregulated in both granulosa and theca cells, putatively 224 
through the effects of at least 3 different miRNAs.  Within the follicle, VEGFA has strong 225 
trophic effects not only in vascular cells but also in steroidogenic cells [28,29]. A key 226 
transcriptional activator of VEGFA is HIF1A [30]. This is a gonadotropin-induced, master 227 
regulator of cellular responses to hypoxia which expression in granulosa cells mediates 228 
survival, steroidogenic and angiogenic responses within the follicle [30,31]. HIF1A is 229 
reportedly expressed at higher levels in granulosa than theca within non-atretic follicles [32]. 230 
These observations are consistent with our finding of a simultaneous decrease in the 231 
expression of HIF1A and VEGFA during bovine follicle atresia, particularly in granulosa 232 
cells. Our results implicate a network of miRNAs, namely, miR-199a-5p, miR-155, miR-150 233 
and miR-378, in the down-regulation of the HIF1A-VEGF effector system during atresia, 234 
with one miRNA, miR-199a-5p, simultaneously targeting both genes, as reported in other cell 235 
types [33].     236 
Two miRNA targets identified in theca cells and which, albeit much less characterized, 237 
may also be involved in angiogenesis, are the transcription factor, ETS1, and the NOTCH1 238 
ligand, JAG1. ETS1 is a proto-oncogen highly expressed in immune and vascular cells. In the 239 
ovary, it has been shown to be expressed in theca and granulosa cells and its expression to 240 
dynamically change during the estrous cycle [34,35]. An involvement of ETS1 in regulating 241 
RGS2 expression during ovulation has been shown [36]. Moreover, its role in promoting 242 
angiogenesis or as a pro-apoptotic factor in different cell types [37] could account for the 243 
changes in expression during follicle atresia. Likewise, apart from its reported role in 244 
promoting early follicle development, little information is available on the role of JAG1 in 245 
the ovary. An involvement of JAG1 in follicular angiogenesis is suggested by its expression 246 
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in endothelial and other vascular mural cells in mouse ovaries [38].  The reason for the 247 
opposite trends in JAG1 expression in granulosa and theca cells of healthy and atretic 248 
follicles in our study is unknown, warranting further study of the functions of this gene in the 249 
adult ovary.  250 
MSH2, a gene involved in DNA mismatch repair, was confirmed as a target of miR-155 in 251 
theca cells. This is consistent with the finding in cattle that atresia involves the 252 
downregulation of cell cycle and DNA replication genes in theca cells rather than the 253 
downregulation of apoptotic genes as occurs in granulosa cells [39]. Interestingly, a study 254 
showed that another miRNA, miR-26a, targeted the cell cycle checkpoint kinase, ATM, in 255 
porcine follicular cells during atresia, leading to increased DNA breaking and apoptosis, and 256 
raising the possibility that miR-155 could exert a similar effect through targeting MSH2 in 257 
bovine theca cells. 258 
Finally, because of the heterogeneous nature of follicular tissue, particular theca, it is not 259 
possible to determine, from our data, the specific cell types involved in the identified 260 
miRNA-target interactions.  For example, although most of the miRNAs analyzed in this 261 
study are known not to be cell-specific, miR-150 and miR-155 are highly expressed and 262 
primarily regulate hematopoietic and vascular cells. Nonetheless, paracrine regulation of gene 263 
expression by miRNAs has also been described whereby miRNAs are produced by one cell 264 
type and then secreted to regulate gene expression of a different cell type within a tissue [40], 265 
adding further complexity to the role of miRNA-target interactions during follicular atresia.  266 
In summary, by establishing the expression patterns of miRNAs and their putative targets 267 
in granulosa and theca cells of healthy and atretic follicles in cattle we have identified a 268 
network of miRNAs including miR-199a-5p, miR-155, miR-222, miR-150 and miR-378 269 
which we propose are involved in follicle atresia through combined targeting of genes 270 
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involved in cell survival, proliferation and differentiation; namely HIF1A and VEGFA in 271 
granulosa cells, and MSH2, ETS1, JAG1 and VEGFA in theca cells.  Although the identified 272 
miRNA-target interactions should be confirmed by gene targeting or other molecular 273 
approaches in future studies, our results will provide fertile ground for further hypothesis-274 
testing towards a better understanding of the molecular mechanisms involved in follicle 275 
atresia.   276 
 277 
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 398 
Figure legends 399 
Figure 1. Mean (± SE) concentrations of Estradiol, Progesterone, and transcript levels of 400 
CYP19A1 and LHCGR in bovine follicles (9-17 mm) classified as healthy (n = 26) or atretic 401 
(n = 15).  Differences between group means are indicated by asterisks (P ≤ 0.05).  Data 402 
adapted from Sontakke et al. 2014 403 
Figure 2. Relative miRNA levels (Mean ± SE; normalized to levels of RnU6-2) in 404 
granulosa and theca cells from bovine healthy (n = 9) and atretic (n = 6) follicles. Differences 405 
between group means within each Cell type are indicated by an asterisk (P < 0.05). 406 
Figure 3. Relative mRNA levels (Mean ± SE; normalized to levels of 18S) in granulosa 407 
and theca cells from bovine healthy (n = 9) and atretic (n = 6) follicles.  Genes confirmed as 408 
miRNA targets by PCR are shown in A), other genes are shown in B). Putative targeting 409 
miRNAs are shown on top of the corresponding graph bars in A); all indicated miRNA-target 410 
interaction were obtained from miRTarBase (database of experimentally validated miRNA-411 
target interactions in human and/or rodents), and interactions that were in addition 412 
 19 
 
computationally predicted in cattle (obtained from TargetScan) are indicated by miRNAs in 413 
bold (e.g., miR-199a-5p-HIF1A). Differences between group means within each Cell type are 414 
indicated by an asterisk (P < 0.05). 415 
Figure 4. Schematic summary of putative miRNA-target interactions in granulosa and 416 
theca cells during follicular atresia identified in this study. 417 
 418 
Table 1. Primer sequences used in mRNA analyses 419 
Gene Sequence (5’-3’) sense / antisense 
18S GCTGGCACCAGACTTG / GGGGAATCAGGGTTCG 
CYP19A1 CGCAAAGCCTTAGAGGATGA / ACCATGGTGATGTACTTTCC 
E2F2 TCGCTATGACACATCGCTGG / CGTCACGTAGGCCAGTCTCT 
ETS1 CACAGTCTCTCCGGCAAAGT / GTGGATGATAGGCCGACTGG 
HIF1A CAGAAGAACTTTTGGGCCGC / TCCACCTCTTTTGGCAAGCA 
IGF1 AGTGCTGCTTTTGTGATTTCTTGA / GCACACGAACTGGAGAGCAT 
IGF1R AAGCTGAGAAGCAGGCAGAG / CGGAGGTTGGAGATGACAGT 
JAG1 GAGTGTGAGTGTTCTCCGGG / TTGGCCTCGCATTCATTTGC 
LHCGR GGACTCTAGCCCGTAGG / ACACATAACCACCATACCAAG 
MSH2 TGGGCAGAAGTGTCCATTGT / CCCACGCTAATCCAAACCCA 
MYD88 AAGTTGTGCGTGTCTG / GGAAATCACATTCCTTGCT 
PAPPA TTGCTGCGCTTCTACAGTGA / GCACAGTCACCCTGTAGGTC 
RECK GTGCTTCCTTCTCTTGTCTGGA / GGCTTGACAGTATTCTCGGC 
SIRT1 GCTTACAGGGCCTATCCAGG / TATGGACCTATCCGAGGTCTTG 
TIMP3 GGATTCACCAAGATGCCCCA / GAGCTGGTCCCACCTCTCTA 
VEGFA TGTAATGACGAAAGTCTGGAG / TCACCGCCTCGGCTTGTCACA 
 20 
 
Table 2. Bovine miRNA sequences which expression was upregulated (> 1.5 fold) in 420 
Atretic relative to Healthy follicles*.  421 
 Microarray RT-qPCR 
miRNA Fold Change 
Adjusted 
P-value** 
Fold 
Change P-value 
bta-miR-483/hsa-miR-483-3p 3.64 0.001 0.88 0.409 
bta-miR-21-3p/hsa-miR-21-3p 3.09 0.002 3.38 0.021 
bta-miR-150/hsa-miR-150-5p 2.54 0.001 2.92 0.001 
bta-miR-21-5p/ hsa-miR-21-5p 2.39 0.001 4.90 0.001 
bta-miR-409a/hsa-miR-409a-5p 2.36 0.000 1.85 0.001 
bta-miR-744/hsa-miR-744-5p 2.36 0.002 0.73 0.057 
bta-miR-142-5p/hsa-miR-142-5p 2.03 0.001 2.81 0.001 
bta-miR-378/has-miR-378a-3p 1.91 0.001 1.51 0.017 
bta-miR-222/hsa-miR-222-3p 1.84 0.000 1.92 0.001 
bta-miR-155/hsa-miR-155-5p 1.66 0.019 5.66 0.001 
bta-miR-199a-5p/hsa-miR-199a-5p 1.63 0.004 1.66 0.001 
* Microarray analyses were performed in 6 healthy and 5 atretic follicles (12-17 mm in diameter) in a 
previous study (data adapted from Sontakke et al., 2014). Microarray data were validated by qPCR in the present 
study using 26 healthy and 15 atretic follicles (9-17 mm in diameter). 
**FDR; Benjamini and Hochberg adjustment 
 
 422 
Table 3. Candidate miRNA-target interactions that were analysed by qPCR (see Figure 3) 423 
 miR-142-5p miR-150 miR-155 miR-199a-5p miR-21-5p miR-222 miR-378 
ETS1        
JAG1        
RECK        
TIMP3        
HIF1A        
IGF1R        
MSH2        
VEGFA        
MYD88        
IGF1        
PAPPA        
High-confidence miRNA-target interactions obtained from both miRTarBase and TargetScan (i.e., that both 424 
have been experimentally validated in human, rat and/or mouse and are computationally predicted in bovine) are 425 
shown in dark grey. Medium-confidence interactions obtained from miRTarBase only are shown in light grey. 426 
Low-confidence interactions obtained from TargetScan only are indicated by an “X”.  427 
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